Program & Downloads

Click here to download the program

Read articles from Liver International

Watch the video about Therapeutic revolution in hepatitis C (january 2013)

Click here to see the speakers list

CONGRESS 2013

08:30 Introduction: Treatment of hepatitis C: the cure - Patrick MARCELLIN (France) Download

08:40 Research in viral hepatitis: the French ANRS experience - Jean-François DELFRAISSY (France) Download

08:50 - 09:20 State of the art lecture
Chairman:
Tarik ASSELAH (France)

Targets for HCV therapy: clinical applications - Charles RICE (USA)

09:20 - 10:30 How to optimize current therapy of G1 patients
Chairs :
Nezam AFDHAL (USA) Massimo COLOMBO (Italy)

09:20 Optimal treatment with telaprevir - Ira JACOBSON (USA) Download

09:35 Optimal treatment with boceprevir - Michael MANNS (Germany) Download

09:50 Predictors of response - Antonio CRAXI (Italy) Download

10:05 Management of side effects - Sam LEE (Canada) Download

10:20 Round table discussion

10:40 - 11:00 Coffee break

11:00 - 12:30 How to optimize current therapy of non G1 patients
Chairs :
Mark THURSZ (UK) Jake LIANG (USA)

11:00 Genotype 2 - Alessio AGHEMO (Italy) Download

11:15 Genotype 3 - Graham FOSTER (UK) Download

11:30 Genotype 4 - Gamal ESMAT (Egypt) Download

11:45 Round table discussion

12:00 – 12:30 State of the art lecture
Chairman:
Patrick MARCELLIN (France)

Milestones in therapy of liver diseases - Jenny HEATHCOTE (Canada) Download

12:30 – 14:30 Interactive luncheons

Room 1

G1 naive patients: how to optimize treatment?

Chairs: Antonio CRAXI (Italy) Vlad RATZIU (France)

Speakers:

Raluca PAIS (France)

Vasily ISAKOV (Russia)

Room 2

Resistance to protease inhibitors: is it a real issue?

Chair: Raymond SCHINAZI (USA)

Speakers:

Philippe HALFON (France)

Olivier LADA (France)

Room 3

G4 patients: how to optimize treatment?

Chair: Graham FOSTER (UK)

Speakers:

Gamal ESMAT (Egypt)

Ahmed El RAY (Egypt)

Room 4

How to manage relapsers and non-‐responders to PEG IFN + RBV therapy?

Chairs: Eugene SCHIFF (USA) Laurent CASTERA (France)

Speakers:

Lawrence SERFATY (France)

Maria BUTI (Spain)

Room 5

Triple therapy with telaprevir or boceprevir: management of side effects?

Chair: Michael FRIED (USA)

Speakers:

Vincent DI MARTINO (France)

Peter FERENCI (Austria)

Room 6

Future therapeutic strategies with direct acting antivirals

Chair: Tarik ASSELAH (France)

Speakers:

Robert FLISIAK (Poland)

Liesl HAGAN (USA)

Room 7

Comment optimiser le traitement des malades naïfs ? (French speaking luncheon)

Chairs: Mihai VOICULESCU (Romania) Christophe HEZODE (France)

Speakers:

Najet BELHADJ BRIK (Tunisia)

Raymond SAYEGH (Lebanon)

Room 8

Comment optimiser le traitement des rechuteurs et non répondeurs (French speaking luncheon)

Chairs: Mustapha BENAZZOUZ (Morocco) Daniel DHUMEAUX (France)

Speakers:

Albert TRAN (France)

Jean-Pierre BRONOWICKI (France)

14:30 -16:00 Difficult to treat patients
Chairs :
Michael FRIED (USA) Masao OMATA (Japan)

14:30 Cirrhotic patients - Marc BOURLIERE (France) Download

14:45 Transplant patients - Didier SAMUEL (France)

15:00 HIV co-infected patients - Mark SULKOWSKI (USA) Download

15:15 Round table discussion

15:40 - 16:00 Coffee break

16:00 -17:20 New therapeutic strategies
Chairs :
Rafael ESTEBAN (Spain) Donald JENSEN (USA)

16:00 Best strategies for global HCV eradication - Raymond SCHINAZI (USA) Download

16:15 2^nd generation protease inhibitors - David NELSON (USA) Download

16:30 Polymerase inhibitors - Stefan ZEUZEM (Germany) Download

16:45 IFN-free regimens - Tarik ASSELAH (France) Download

17:00 Round table discussion

17:20 - 17:50 Controversy: F1/F2 patients: treat or wait?
Chairman:
Graham FOSTER (UK)

Treat Mitchell SHIFFMAN (USA) Download Yves BENHAMOU (France) Download

17:50 Conclusion - Patrick MARCELLIN (France)

18:00 Ajournement

19:30 Congress dinner

08:30 Introduction: HBV: viral control or clinical cure? - Patrick MARCELLIN (France) Download

08:40 - 10:00 The control of HBV related liver disease
Chairs :
Henry CHAN (Hong Kong) Antonio CRAXI (Italy)

08:40 Impact of therapy on the outcome of CHB - Yun-Fan LIAW (Taiwan) Download

08:55 Optimal management of patients with resistance - Fabien ZOULIM (France) Download

09:10 HBsAg quantitation ; clinical applications - Michelle MARTINOT-PEIGNOUX (France) Download

09:25 Round table discussion

10:00 - 10:30 Coffee break

10:30 - 11:30 Optimal therapy of HBeAg-positive chronic hepatitis B
Chairs :
Jia-Horng KAO (Taiwan) Eugene SCHIFF (USA)

10:30 Why do I treat my patient with a NUC? - Jidong JIA (China) Download

10:45 Why do I treat my patient with pegylated IFN? - Geoffrey DUSHEIKO (UK) Download

11:00 Round table discussion

11:30 - 12:30 Optimal therapy of HBeAg-negative chronic hepatitis B
Chairs :
Seng Gee LIM (Singapore) Feruccio BONINO (Italy)

11:30 Why do I treat my patient with a NUC? - Georgios PAPATHEODORIDIS (Greece) Download

11:45 Why do I treat my patient with pegylated IFN? - Pietro LAMPERTICO (Italy) Download

12:00 Round table discussion

12:30 - 14:30 Interactive Luncheons

Room 1

Should immunotolerant and inactive carriers be treated?

Chair: Pietro LAMPERTICO (Italy)

Speakers:

Adrian GADANO (Argentina)

Sam LEE (Canada)

Room 2

Long term impact of treatment on the outcome of the liver disease?

Chair: Yun-Fan LIAW (Taiwan)

Speakers:

Philippe MATHURIN (France)

Yazdan YAZDANPANAH (France)

Room 3

First line therapy: interferon or analogue?

Chair: Massimo COLOMBO (Italy)

Speakers:

George LAU (Hong Kong)

Thomas BERG (Germany)

Room 4

Treatment of patients with resistant HBV?

Chair: Geoffrey DUSHEIKO (UK)

Speakers:

Georgios PAPATHEODORIDIS (Greece)

Vincent LEROY (France)

Room 5

The clinical applications of HBsAg quantification

Chair: Henry CHAN (Hong Kong)

Speakers:

Michelle MARTINOT-PEIGNOUX (France)

Philippe HALFON (France)

Room 6

Fibrosis staging: liver biopsy or indirect markers?

Chair: Nezam AFDHAL (USA)

Speakers:

Victor DE LEDINGHEN (France)

Ana Carolina CARDOSO (Brazil)

Room 7

Interféron ou analogue ? (French speaking luncheon)

Chairs: Jean-Pierre ZARSKI (France) Zahari KRASTEV (Bulgaria)

Speakers:

Rami MOUCARI (United Arab Emirates)

Rachid OULD GOUGAM (Algeria)

Room 8

Faut-‐il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon)

Chairs: Christian TREPO (France) Jean-François David CADRANEL (France)

Speakers:

Adriana POPESCU (Romania)

14:30 - 16:30 Therapy in special populations
Chairs :
Jean-Pierre ZARSKI (France) Massimo LEVRERO (France)